Central Nervous System Cancer-Refresher 2017 is organized by American Society for Radiation Oncology (ASTRO) and will be held from Sep 14, 2017 - Sep 13, 2020.

The target audience for this medical event is radiation oncologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.

Course Description:
This review session will cover the data upon which the current clinical management is based for both benign and malignant adult CNS tumors. Data-based recommendations from randomized trials will be emphasized as well as clinically relevant practice patterns. The neurocognitive side effects of our treatments will be reviewed. Areas of controversy and future research will be highlighted.

Learning Objectives:
Upon completion of this activity, participants should be able to:
• Describe the current clinical data underlying the treatment of benign and malignant adult CNS tumors.
• Review the data-based recommendations for chemotherapy, surgery and radiotherapy for these tumors.
• Identify the evolving molecular tests in CNS tumors which will guide treatment recommendations.
• Discuss the benefits and side effects of the multiple treatment options for brain metastases.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Neuroscience

Activity Payment Details

Activity Fee : USD $105.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Society for Radiation Oncology (ASTRO)

View Organizer Details